Total Payments
$12,894
2024 Payments
$2,412
Companies
30
Transactions
206
Medicare Patients
8,813
Medicare Billing
$935,073
Payment Breakdown by Category
Other$7,500 (58.2%)
Food & Beverage$5,394 (41.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,500 | 7 | 58.2% |
| Food and Beverage | $5,394 | 199 | 41.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $8,802 | 48 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $974.16 | 35 | $0 (2024) |
| Cardiovascular Systems Inc. | $615.26 | 20 | $0 (2022) |
| Merck Sharp & Dohme LLC | $301.83 | 17 | $0 (2024) |
| PFIZER INC. | $280.29 | 13 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $262.17 | 16 | $0 (2024) |
| ABIOMED | $195.03 | 3 | $0 (2020) |
| Inari Medical, Inc. | $164.19 | 2 | $0 (2024) |
| Abbott Laboratories | $162.34 | 3 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $161.37 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,412 | 43 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($1,702) |
| 2023 | $708.77 | 36 | Merck Sharp & Dohme LLC ($170.98) |
| 2022 | $689.19 | 26 | Inari Medical, Inc. ($140.18) |
| 2021 | $451.31 | 17 | Cardiovascular Systems Inc. ($265.80) |
| 2020 | $1,168 | 18 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($903.39) |
| 2019 | $3,633 | 22 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($3,373) |
| 2018 | $3,293 | 27 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($2,512) |
| 2017 | $537.87 | 17 | Novartis Pharmaceuticals Corporation ($181.57) |
All Payment Transactions
206 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: DIABETES | ||||||
| 12/16/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/06/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: Not Applicable | ||||||
| 10/23/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/02/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: VTE | ||||||
| 09/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/22/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $6.30 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/19/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $6.14 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/07/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $27.69 | General |
| Category: Cardiology | ||||||
| 07/08/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $20.38 | General |
| 06/26/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: Not Applicable | ||||||
| 05/23/2024 | Pharmacosmos Therapeutics Inc. | COSELA (Drug) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: HEMATOLOGY | ||||||
| 05/22/2024 | CORDIS US CORP. | MYNXGRIP (Device) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: Cardiovascular | ||||||
| 05/20/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $7.92 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/09/2024 | Baxter Healthcare | BioPharma Sol - Contract Manuf (Biological) | Food and Beverage | In-kind items and services | $47.53 | General |
| Category: BioPharma Solutions | ||||||
| 05/06/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/01/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $27.44 | General |
| Category: Not Applicable | ||||||
| 04/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $29.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/29/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $23.48 | General |
| 04/11/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $8.27 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/08/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $29.56 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/01/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,631 | 5,091 | $730,803 | $274,155 |
| 2022 | 25 | 2,435 | 4,333 | $679,755 | $238,024 |
| 2021 | 17 | 1,809 | 2,950 | $456,678 | $191,982 |
| 2020 | 14 | 1,938 | 3,355 | $547,973 | $230,912 |
Total Patients
8,813
Total Services
15,729
Medicare Billing
$935,073
Procedure Codes
89
All Medicare Procedures & Services
89 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 272 | 880 | $114,400 | $57,262 | 50.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 169 | 438 | $100,645 | $45,374 | 45.1% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 67 | 259 | $54,390 | $32,386 | 59.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 213 | 240 | $60,000 | $25,769 | 42.9% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 57 | 500 | $50,000 | $19,975 | 40.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 352 | 358 | $85,810 | $19,711 | 23.0% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 53 | 415 | $45,650 | $17,185 | 37.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 861 | 1,255 | $62,128 | $8,202 | 13.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 87 | 182 | $14,560 | $7,497 | 51.5% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 47 | 47 | $11,750 | $7,008 | 59.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 33 | 38 | $18,644 | $5,900 | 31.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 43 | 43 | $14,942 | $5,602 | 37.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 32 | 32 | $14,880 | $4,563 | 30.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 28 | 40 | $9,600 | $3,915 | 40.8% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 44 | 82 | $6,995 | $2,667 | 38.1% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 13 | 13 | $25,217 | $2,465 | 9.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 19 | 19 | $6,650 | $2,090 | 31.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 13 | 19 | $4,370 | $1,521 | 34.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 17 | $2,637 | $1,159 | 43.9% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 62 | 62 | $3,720 | $1,036 | 27.9% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 62 | 62 | $3,100 | $696.26 | 22.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 11 | 12 | $1,800 | $651.12 | 36.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 11 | 11 | $12,058 | $619.46 | 5.1% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 18 | 18 | $810.00 | $283.53 | 35.0% |
| 93225 | Electrocardiogram (ecg) 2-day continuous | Office | 2023 | 12 | 12 | $1,680 | $170.94 | 10.2% |
About Dr. Aziz Ahmed, M.D
Dr. Aziz Ahmed, M.D is a Internal Medicine healthcare provider based in Bloomingdale, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1962403998.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aziz Ahmed, M.D has received a total of $12,894 in payments from pharmaceutical and medical device companies, with $2,412 received in 2024. These payments were reported across 206 transactions from 30 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($7,500).
As a Medicare-enrolled provider, Ahmed has provided services to 8,813 Medicare beneficiaries, totaling 15,729 services with total Medicare billing of $935,073. Data is available for 4 years (2020–2023), covering 89 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Interventional Cardiology
- Location Bloomingdale, IL
- Active Since 08/01/2005
- Last Updated 09/27/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1962403998
Products in Payments
- LifeVest (Device) $8,802
- ENTRESTO (Drug) $765.57
- ELIQUIS (Drug) $370.26
- Diamondback Peripheral (Device) $361.93
- VERQUVO (Drug) $301.83
- Peripheral Orbital Atherectomy System (Device) $231.43
- LEQVIO (Drug) $208.59
- Impella (Device) $195.03
- FLOWTRIEVER CATHETER, S (Device) $164.19
- XARELTO (Drug) $142.98
- Mitra Clip system (Device) $139.35
- BRILINTA (Drug) $107.44
- ANGIOJET (Device) $93.59
- Arcalyst (Drug) $80.69
- CAMZYOS (Drug) $79.67
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $70.09
- Assure WCD (Device) $57.66
- FARXIGA (Drug) $53.93
- PRADAXA (Drug) $48.99
- BioPharma Sol - Contract Manuf (Biological) $47.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bloomingdale
Vanja Cuk, Md, MD
Internal Medicine — Payments: $8,808
Internal Medicine $8,808
Dr. Sanjay Patel, M.d, M.D
Internal Medicine — Payments: $5,443
Internal Medicine $5,443
Dr. Mahrukh Subhani, M.d, M.D
Internal Medicine — Payments: $2,723
Internal Medicine $2,723
Robert Hurst, Md, MD
Internal Medicine — Payments: $1,136
Internal Medicine $1,136
Sonal Patel, Do, DO
Internal Medicine — Payments: $753.69
Internal Medicine $753.69
Wahaj Ahmed, M.d, M.D
Internal Medicine — Payments: $670.83
Internal Medicine $670.83